Faeth Therapeutics | The GOG Foundation, Inc. (IMAGE)

The GOG Foundation Inc

Faeth Therapeutics | The GOG Foundation, Inc.

Caption

FAETH THERAPEUTICS AND THE GOG FOUNDATION, INC. (GOG-F) LAUNCH FIRST PHASE 2 COMBINATION TRIAL FOR SAPANISERTIB-SERABELISIB IN PATIENTS WITH ENDOMETRIAL CANCER

Credit

Faeth Therapeutics | The GOG Foundation, Inc.

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.